These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A novel multiplex-protein array for serum diagnostics of colorectal cancer: impact of pre-analytical storage conditions. Bünger S; Klempt-Giessing K; Toner V; Kelly M; FitzGerald SP; Brenner H; von Eggeling F; Habermann JK Biopreserv Biobank; 2013 Dec; 11(6):379-86. PubMed ID: 24835368 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852 [TBL] [Abstract][Full Text] [Related]
5. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer. Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721 [TBL] [Abstract][Full Text] [Related]
6. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer. Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598 [TBL] [Abstract][Full Text] [Related]
7. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas. Taguchi A; Rho JH; Yan Q; Zhang Y; Zhao Y; Xu H; Tripathi SC; Wang H; Brenner DE; Kucherlapati M; Kucherlapati R; Boutin AT; Wang YA; DePinho RA; Feng Z; Lampe PD; Hanash SM Cancer Prev Res (Phila); 2015 Nov; 8(11):1112-9. PubMed ID: 26342024 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1. Attallah AM; El-Far M; Ibrahim AR; El-Desouky MA; Omran MM; Elbendary MS; Attallah KA; Qura ER; Abdallah SO Br J Biomed Sci; 2018 Jul; 75(3):122-127. PubMed ID: 29734875 [TBL] [Abstract][Full Text] [Related]
9. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer. Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169 [TBL] [Abstract][Full Text] [Related]
10. Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Rho JH; Ladd JJ; Li CI; Potter JD; Zhang Y; Shelley D; Shibata D; Coppola D; Yamada H; Toyoda H; Tada T; Kumada T; Brenner DE; Hanash SM; Lampe PD Gut; 2018 Mar; 67(3):473-484. PubMed ID: 27821646 [TBL] [Abstract][Full Text] [Related]
11. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence. Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T Oncology; 2017; 92(5):276-282. PubMed ID: 28178692 [TBL] [Abstract][Full Text] [Related]
12. Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancer. Perez CA; Ravindranath MH; Gupta RK; Tollenaar RA; van de Velde CJ; Wood TF; Soh D; Morton DL; Bilchik AJ Cancer J; 2002; 8(1):55-61. PubMed ID: 11898807 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic significance of serum HMGB1 in colorectal carcinomas. Lee H; Song M; Shin N; Shin CH; Min BS; Kim HS; Yoo JS; Kim H PLoS One; 2012; 7(4):e34318. PubMed ID: 22496788 [TBL] [Abstract][Full Text] [Related]
14. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma]. Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of a Novel Multiplex Immunoassay in Colorectal Cancer. Dressen K; Hermann N; Manekeller S; Walgenbach-Bruenagel G; Schildberg FA; Hettwer K; Uhlig S; Kalff JC; Hartmann G; Holdenrieder S Anticancer Res; 2017 May; 37(5):2477-2486. PubMed ID: 28476816 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of specific fecal protein biochips for the diagnosis of colorectal cancer. Wang HP; Wang YY; Pan J; Cen R; Cai YK World J Gastroenterol; 2014 Feb; 20(5):1332-9. PubMed ID: 24574808 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value evaluation of trefoil factors family 3 for the early detection of colorectal cancer. Xie H; Guo JH; An WM; Tian ST; Yu HP; Yang XL; Wang HM; Guo Z World J Gastroenterol; 2017 Mar; 23(12):2159-2167. PubMed ID: 28405143 [TBL] [Abstract][Full Text] [Related]
18. Circulating midkine in malignant and non-malignant colorectal diseases. Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719 [TBL] [Abstract][Full Text] [Related]
19. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer. Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510 [TBL] [Abstract][Full Text] [Related]
20. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen. Carpelan-Holmström MA; Haglund CH; Roberts PJ Dis Colon Rectum; 1996 Jul; 39(7):799-805. PubMed ID: 8674374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]